These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38839372)

  • 21. Optimization of phospholipid chemistry for improved lipid nanoparticle (LNP) delivery of messenger RNA (mRNA).
    Álvarez-Benedicto E; Farbiak L; Márquez Ramírez M; Wang X; Johnson LT; Mian O; Guerrero ED; Siegwart DJ
    Biomater Sci; 2022 Jan; 10(2):549-559. PubMed ID: 34904974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DoE-derived continuous and robust process for manufacturing of pharmaceutical-grade wide-range LNPs for RNA-vaccine/drug delivery.
    Nag K; Sarker MEH; Kumar S; Khan H; Chakraborty S; Islam MJ; Baray JC; Khan MR; Mahmud A; Barman U; Bhuiya EH; Mohiuddin M; Sultana N
    Sci Rep; 2022 Jun; 12(1):9394. PubMed ID: 35672337
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A fluorinated ionizable lipid improves the mRNA delivery efficiency of lipid nanoparticles.
    Huo H; Cheng X; Xu J; Lin J; Chen N; Lu X
    J Mater Chem B; 2023 May; 11(19):4171-4180. PubMed ID: 37129135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Production of siRNA-Loaded Lipid Nanoparticles using a Microfluidic Device.
    Maeki M; Okada Y; Uno S; Niwa A; Ishida A; Tani H; Tokeshi M
    J Vis Exp; 2022 Mar; (181):. PubMed ID: 35404350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Continuous production of lipid nanoparticles by multiple-splitting in microfluidic devices with chaotic microfibrous channels.
    Ahn GY; Choi I; Ryu TK; Ryu YH; Oh DH; Kang HW; Kang MH; Choi SW
    Colloids Surf B Biointerfaces; 2023 Apr; 224():113212. PubMed ID: 36822116
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A preparation method for mRNA-LNPs with improved properties.
    Geng C; Zhou K; Yan Y; Li C; Ni B; Liu J; Wang Y; Zhang X; Wang D; Lv L; Zhou Y; Feng A; Wang Y; Li C
    J Control Release; 2023 Dec; 364():632-643. PubMed ID: 37956926
    [TBL] [Abstract][Full Text] [Related]  

  • 27. pH-Dependent Phase Behavior and Stability of Cationic Lipid-mRNA Nanoparticles.
    Larson NR; Hu G; Wei Y; Tuesca AD; Forrest ML; Middaugh CR
    J Pharm Sci; 2022 Mar; 111(3):690-698. PubMed ID: 34774918
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of Lipid Nanoparticles Containing Ionizable Cationic Lipids Using Design-of-Experiments Approach.
    Terada T; Kulkarni JA; Huynh A; Chen S; van der Meel R; Tam YYC; Cullis PR
    Langmuir; 2021 Jan; 37(3):1120-1128. PubMed ID: 33439022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of an imaged capillary isoelectric focusing method for characterizing the surface charge of mRNA lipid nanoparticle vaccines.
    Loughney JW; Minsker K; Ha S; Rustandi RR
    Electrophoresis; 2019 Sep; 40(18-19):2602-2609. PubMed ID: 31218707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigations into mRNA Lipid Nanoparticles Shelf-Life Stability under Nonfrozen Conditions.
    Reinhart AG; Osterwald A; Ringler P; Leiser Y; Lauer ME; Martin RE; Ullmer C; Schumacher F; Korn C; Keller M
    Mol Pharm; 2023 Dec; 20(12):6492-6503. PubMed ID: 37975733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Electrophoretic Microfluidic Characterization of mRNA- and pDNA-Loaded Lipid Nanoparticles.
    De Peña AC; Zimmer D; Gutterman-Johns E; Chen NM; Tripathi A; Bailey-Hytholt CM
    ACS Appl Mater Interfaces; 2024 May; 16(21):26984-26997. PubMed ID: 38753459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bivalent mRNA vaccines against three SARS-CoV-2 variants mediated by new ionizable lipid nanoparticles.
    Wang J; Zhang Y; Dong S; Zha W; Liu C; Wang Y; Jiang Y; Xing H; Li X
    Int J Pharm; 2023 Jul; 642():123155. PubMed ID: 37402442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biodistribution and Non-linear Gene Expression of mRNA LNPs Affected by Delivery Route and Particle Size.
    Di J; Du Z; Wu K; Jin S; Wang X; Li T; Xu Y
    Pharm Res; 2022 Jan; 39(1):105-114. PubMed ID: 35080707
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Size-controlled lipid nanoparticle production using turbulent mixing to enhance oral DNA delivery.
    He Z; Hu Y; Nie T; Tang H; Zhu J; Chen K; Liu L; Leong KW; Chen Y; Mao HQ
    Acta Biomater; 2018 Nov; 81():195-207. PubMed ID: 30267888
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipid nanoparticle formulations for optimal RNA-based topical delivery to murine airways.
    Tam A; Kulkarni J; An K; Li L; Dorscheid DR; Singhera GK; Bernatchez P; Reid G; Chan K; Witzigmann D; Cullis PR; Sin DD; Lim CJ
    Eur J Pharm Sci; 2022 Sep; 176():106234. PubMed ID: 35688311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Morphological Characterization of Self-Amplifying mRNA Lipid Nanoparticles.
    Thelen JL; Leite W; Urban VS; O'Neill HM; Grishaev AV; Curtis JE; Krueger S; Castellanos MM
    ACS Nano; 2024 Jan; 18(2):1464-1476. PubMed ID: 38175970
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enabling online determination of the size-dependent RNA content of lipid nanoparticle-based RNA formulations.
    Jia X; Liu Y; Wagner AM; Chen M; Zhao Y; Smith KJ; Some D; Abend AM; Pennington J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Dec; 1186():123015. PubMed ID: 34741934
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Payload distribution and capacity of mRNA lipid nanoparticles.
    Li S; Hu Y; Li A; Lin J; Hsieh K; Schneiderman Z; Zhang P; Zhu Y; Qiu C; Kokkoli E; Wang TH; Mao HQ
    Nat Commun; 2022 Sep; 13(1):5561. PubMed ID: 36151112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis of novel cholesterol-based ionizable lipids for mRNA delivery.
    Qian R; Ullah A; Cui J; Cai X; Cao J; Wu L; Shen S
    Colloids Surf B Biointerfaces; 2024 Aug; 240():113980. PubMed ID: 38781845
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microfluidic technologies and devices for lipid nanoparticle-based RNA delivery.
    Maeki M; Uno S; Niwa A; Okada Y; Tokeshi M
    J Control Release; 2022 Apr; 344():80-96. PubMed ID: 35183654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.